Upfront Immunotherapy for Metastatic Kidney Cancer – OncLive
OncLive |
Upfront Immunotherapy for Metastatic Kidney Cancer
OncLive Panelists: Robert A. Figlin, MD, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center; Eric Jonasch, MD, University of Texas MD Anderson Cancer Center; Toni K. Choueiri, MD, Dana-Farber Cancer Institute; Michael R. Harrison, … |
